MEDPACE HOLDINGS INC

NASDAQ: MEDP (Medpace Holdings, Inc.)

Last update: 01 Nov, 12:57AM

314.22

-4.13 (-1.30%)

Previous Close 318.35
Open 316.09
Volume 328,853
Avg. Volume (3M) 342,804
Market Cap 9,766,460,416
Price / Earnings (TTM) 27.54
Price / Earnings (Forward) 25.13
Price / Sales 5.37
Price / Book 13.86
52 Weeks Range
266.66 (-15%) — 459.77 (46%)
Earnings Date 21 Oct 2024
Profit Margin 16.74%
Operating Margin (TTM) 19.91%
Diluted EPS (TTM) 10.64
Quarterly Revenue Growth (YOY) 14.60%
Quarterly Earnings Growth (YOY) 44.70%
Total Debt/Equity (MRQ) 20.13%
Current Ratio (MRQ) 0.880
Operating Cash Flow (TTM) 539.85 M
Levered Free Cash Flow (TTM) 419.36 M
Return on Assets (TTM) 14.33%
Return on Equity (TTM) 58.85%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bullish Mixed
Diagnostics & Research (Global) Bullish Mixed
Stock Medpace Holdings, Inc. Bearish Bullish

Stockmoo Score

0.6
Analyst Consensus 1.0
Insider Activity NA
Price Volatility 2.0
Technical Moving Averages 0.0
Technical Oscillators -0.5
Average 0.63

Similar Stocks

Stock Market Cap DY P/E P/B
MEDP 10 B - 27.54 13.86
RDNT 5 B - 395.00 5.77
VCYT 3 B - - 2.40
MYGN 2 B - - 2.14
CDNA 1 B - - 4.51
CSTL 895 M - - 2.07

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Growth
% Held by Insiders 17.80%
% Held by Institutions 85.70%

Ownership

Name Date Shares Held
Findlay Park Partners Llp 30 Jun 2024 475,900
Westwind Capital 30 Jun 2024 380,929
52 Weeks Range
266.66 (-15%) — 459.77 (46%)
Price Target Range
345.00 (9%) — 404.00 (28%)
High 404.00 (Redburn Atlantic, 28.57%) Buy
Median 361.00 (14.89%)
Low 345.00 (Jefferies, 9.80%) Hold
Average 369.50 (17.59%)
Total 2 Buy, 4 Hold
Avg. Price @ Call 336.53
Firm Date Target Price Call Price @ Call
Baird 23 Oct 2024 349.00 (11.07%) Hold 330.07
20 Sep 2024 413.00 (31.44%) Buy 365.70
TD Cowen 23 Oct 2024 372.00 (18.39%) Buy 330.07
Redburn Atlantic 14 Oct 2024 404.00 (28.57%) Buy 353.50
Truist Securities 14 Oct 2024 397.00 (26.34%) Hold 353.50
UBS 27 Sep 2024 350.00 (11.39%) Hold 331.44
Jefferies 25 Sep 2024 345.00 (9.80%) Hold 320.58

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria